[4,4-difluoro-2-[[4-(morpholine-4-carbonyl)triazol-1-yl]methyl]pyrrolidin-1-yl]-(2-ethylpyrazol-3-yl)methanone
C18H23F2N7O3 — CID 171144365
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4,4-difluoro-2-[[4-(morpholine-4-carbonyl)triazol-1-yl]methyl]pyrrolidin-1-yl]-(2-ethylpyrazol-3-yl)methanone
[4,4-difluoro-2-[[4-(morpholine-4-carbonyl)triazol-1-yl]methyl]pyrrolidin-1-yl]-(2-ethylpyrazol-3-yl)methanone (PubChem CID 171144365) has the molecular formula C18H23F2N7O3 and a molecular weight of 423.42 g/mol. Its IUPAC name is [4,4-difluoro-2-[[4-(morpholine-4-carbonyl)triazol-1-yl]methyl]pyrrolidin-1-yl]-(2-ethylpyrazol-3-yl)methanone.
Molecular Properties
| Compound Name | [4,4-difluoro-2-[[4-(morpholine-4-carbonyl)triazol-1-yl]methyl]pyrrolidin-1-yl]-(2-ethylpyrazol-3-yl)methanone |
|---|---|
| PubChem CID | 171144365 |
| Molecular Formula | C18H23F2N7O3 |
| Molecular Weight | 423.42 g/mol |
| Exact Mass | 423.18 |
| IUPAC Name | [4,4-difluoro-2-[[4-(morpholine-4-carbonyl)triazol-1-yl]methyl]pyrrolidin-1-yl]-(2-ethylpyrazol-3-yl)methanone |
| SMILES | CCn1nccc1C(=O)N1CC(F)(F)CC1Cn1cc(C(=O)N2CCOCC2)nn1 |
| InChI | InChI=1S/C18H23F2N7O3/c1-2-27-15(3-4-21-27)17(29)26-12-18(19,20)9-13(26)10-25-11-14(22-23-25)16(28)24-5-7-30-8-6-24/h3-4,11,13H,2,5-10,12H2,1H3 |
| InChIKey | VNOLVOUEIXXADX-UHFFFAOYSA-N |
| XLogP | 0.52 |
| TPSA | 98.38 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 423.42 |
| LogP ≤ 5 | 0.52 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 171144365 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.